| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |